A lower-limb rehabilitation monitoring system for post-stroke patients developed by a group of five students has received a ...
Zacks Investment Research on MSN
CBLL wins FDA breakthrough status for AI-based LVO stroke detection
CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...
HELSINKI — Use of a novel algorithm significantly improved prehospital triage for stroke, more accurately directing appropriate patients to centers equipped for endovascular therapy (EVT) and boosting ...
Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
Investing.com -- CeriBell, Inc. (NASDAQ:CBLL) stock jumped 8% on Monday after the medical technology company announced it received FDA Breakthrough Device Designation for its Large Vessel Occlusion ...
Most older adults prescribed gabapentin after a stroke kept getting the drug for at least 1 year. Gabapentin is used off-label for post-stroke pain, despite limited guidelines and safety concerns. The ...
Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke as compared with aspirin alone when treatment is initiated early (≤24 hours) after an acute mild stroke. The effect of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback